Want to join the conversation?
Biotech company $BIIB said that as of March 31, 2016 and Dec. 31, 2015, its strategic investment portfolio comprised of investments totaling $102MM and $96MM, respectively. $BIIB's strategic investment portfolio includes investments in equity securities of some biotechnology companies and investments in VC funds.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.